MedCity News November 11, 2024
Matt Manning

Top challenges impacting specialty pharmacy outcomes, and how health systems may achieve efficiencies and enhance performance for optimal outcomes.

Specialty medications are estimated to comprise 65% of drug spending by 2025, and health systems are rapidly addressing new industry demands with in-house programs to support high-cost, high-touch drug dispensing.

While entity-owned specialty pharmacies meet a clear need for patients requiring complex therapies, getting these programs up and running is only part of the battle. Without strategic optimization across integrated channels, a specialty pharmacy’s long-term success hangs in the balance, but determining how to approach this endeavor often leaves health systems stumped.

Let’s explore the top challenges impacting specialty pharmacy outcomes, and how health systems may achieve efficiencies and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
Survey Suggests Pharma Industry Still Struggling with Digital Transformation
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights
Kura Oncology Gets $330M to Kick Off Global Leukemia Drug Pact With Kyowa Kirin
What might a Trump administration mean for the Biosecure Act?

Share This Article